Stages of objective memory impairment (SOMI) as a predictor of clinical progression in the A4 study
{{output}}
Background: About one third of amyloid positive, cognitively normal individuals develop mild cognitive impairment or clinical Alzheimer dementia (AD) over 5 years of follow-up. Sensitive cognitive measures, in addition to biomark... ...
